Objectives: The aim of this study was to investigate the hypothesis that a specially designed, static magnet of 2700 gauss, attached over the pelvic area, could relieve menstrual pain.
reduction in the level of pain after 2 weeks.6 There are no other double-blind studies that have looked specifically at static magnets in dysmenorrhea.
The current study was prompted on the basis of increas ing anecdotal evidence for the efficacy of static magnets in relieving dysmenorrhea both from the author's clinical ex perience and from a telephone survey of 193 women with primary dysmenorrhea7 who had owned or purchased the device from the manufacturer. The aim of this study was to examine this apparent efficacy to relieve dysmenorrhea in a controlled manner in volunteers who had regular monthly dysmenorrhea.
MATERIALS AND METHODS
Seventy (70) women responded to an advertisement in the newspaper to take part in this double-blind controlled study of menstrual pain. These respondents were screened by telephone and excluded if they did not experience pain every menstrual cycle or if they had been diagnosed with secondary dysmenorrhea (endometriosis, fibroids, or pelvic inflammatory disease). The remaining 65 women were sent detailed information by mail about the study, a consent form confirming their understanding of the nature of the study and their agreement to take part, and a home McGill ques tionnaire with instructions on how to fill this in. They were told over the phone that they would receive a coded device and that neither they nor the assessor would know whether it was a live device or a placebo. Furthermore they were in formed verbally and in the literature sent to them that this was a study involving a metallic device and that they should continue their usual treatment for menstrual pain if neces sary. Magnetic devices (LadyCare,® Magnopulse, Bristol, UK) were neodymium magnets of 2700 gauss (surface mea surement made by the manufacturer at the body surface of the magnet using a gauss meter) with patented directional plate designed to allow high gauss rating in proportion to small size ( Fig. 1 
Statistical methods
Results were analyzed by an independent universitybased statistician. To compare pain score differences and all other outcomes between the magnet and placebo groups, the Mann-Whitney test (nonparametric test) was used, as the distribution of the pain scores differences and other data in both groups did not appear to be symmetric (that is, nor mally distributed). For all hypothesis tests a 5% significance level (p < 0.05) and two-tailed tests were used. Ninety-five percent (95%) Mann-Whitney confidence intervals (CI) for the median differences between the magnet and placebo groups were determined. Where improvement versus no im provement was compared the x2 test was used.
This analysis was on an intention-to-treat basis insofar as data for the participants were analyzed within the group to which the patients were allocated. However dropout and missing data were not explored and this analysis was of those individuals who completed the study.
This was unlikely to cause bias unless the reason for data being missing was different in the two arms of the study.
RESULTS
The Table 1 .
Both groups were well matched for age; mean age was 29.1 ± 1.52 years in the placebo group and 30.4 ± 1.37 years in the magnet group (p = 0.531).
The usual level of menstrual pain experienced was rated similarly in both groups (placebo group 7.6, magnet group 7.2, p = 0.468). Figure 
Associated symptoms
In all, 71.5% of the magnet group reported a decrease in irritability compared to 32.5% of the placebo group. Figure   3 illustrates the high proportion of women that reported this Side-effects Six (6) women in the placebo group reported unusual symptoms after wearing the device compared to two women in the magnet group. In the placebo group these symptoms were listed as more painful menstrual periods (two women), heavier periods (one), nausea (one), rumbling stomach (one), and diarrhea (one). In the magnet group these were listed as nausea (one) and "fuzzy-headedness" (one).
Role of the funding source
The study sponsor The commonly associated symptoms were experienced to the same degree in both groups. With regard to premenstrual syndrome (PMS) symptoms, subjects were asked if they experienced these, but no definition of PMS was given to the patients. LadyCare® A limition of the study is the small size of the study and also that the effects were only determined over one menstrual cycle. In a recent survey7 of 193 women with primary dysmenorrhea (randomly selected from the manufacturer's cus tomer database) (average duration, 11.6 years), all of whom were using the same magnetic device as in this study. This survey found a highly statistically significant reduction in pain 
